Cromolyn sodium delays disease onset and is neuroprotective in the SOD1G93A mouse model of ALS
In research led by investigators at Massachusetts General Hospital and published in Scientific Reports, treatment with an anti-inflammatory drug delayed the onset of disease in a mouse model of ALS.